No-Shpa Forte 24 tab (No spa, No-spa, Noshpa, Nospa)

Products might cost different amounts at a pharmacy and online. The image of the product may differ from the actual product.

It is taken orally.
Typically, the average daily dose is 120-240 mg (the daily dose is divided into 2-3 doses).

The health is harmed by improper usage! Please carefully read the information in the package booklet or on the packaging!

Contraindications

Hypersensitivity to drotaverine and/or excipients included in the drug.
Severe liver or kidney failure.
Severe heart failure (decreased cardiac output).
Breastfeeding period (see section “Pregnancy and lactation”).
Children's age (no clinical studies have been conducted in children).
Hereditary lactose intolerance, lactase deficiency, galactosemia or glucose/galactose malabsorption syndrome (due to the presence of lactose in the drug) (see “Special Instructions”).
Carefully

For arterial hypotension.

In pregnant women (see section “Pregnancy and lactation”). Pregnancy and lactation

Based on the limited amount of retrospective data on the use of the drug in humans and data from studies in animals when drotaverine is taken orally, there is no evidence of teratogenic or embryotoxic effects, as well as adverse effects on pregnancy. Despite this, when using the drug in pregnant women, caution should be exercised and the drug should be prescribed only after carefully weighing the balance of benefits and risks for the mother and the risk for the child.

Studies on the excretion of drotaverine into human milk in animals have not been conducted. Due to the lack of such studies in animals and clinical data, prescribing drotaverine during lactation is not recommended.

Side effects

The following side effects, which in clinical studies were assessed as at least possibly associated with drotaverine, are given in accordance with the following gradations of their frequency of occurrence: very often (1/10), often (≥1/100, 1/10) ; rare (≥1/1000, 1/100); sometimes (≥1/10000, 1/1000); very rare (including isolated reports) (1/10000); unknown frequency (it is impossible to determine the frequency of occurrence from the available data) and are grouped by organ system.
From the nervous system
Sometimes: headache, dizziness, insomnia.
From the cardiovascular system
Sometimes: increased heart rate, decreased blood pressure.
From the gastrointestinal tract
Sometimes: nausea, constipation.
From the immune system
Sometimes - allergic reactions (angioedema, urticaria, rash, itching) (see section “Contraindications”).
Interaction

With levodopa
With simultaneous use, drotaverine can weaken the antiparkinsonian effect of levodopa, that is, increase rigidity and tremor.
With papaverine, bendazole and other antispasmodics (including m-anticholinergics)
Strengthening the antispasmodic effect.
With morphine
Reducing the spasmogenic activity of morphine. With phenobarbital
Strengthening the antispasmodic effect of drotaverine.

Discuss the use of this medication with your doctor or pharmacist.

Never use the medication for longer than recommended.

Patients with hypersensitivity to the components should NOT use the product.

The customer is responsible for making informed decisions about purchasing and using these products. Any reliance on the information provided herein or the use of products sold on this website is solely at the customer's own risk.
Please read our Healthcare Disclaimer.